TITLE

Cognitive behavioral therapy aided discontinuation of benzodiazepine in chronic insomnia: COMMENTARY

AUTHOR(S)
Bradley, Colin P.
PUB. DATE
May 2004
SOURCE
ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p70
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The conventional approach to benzodiazepine withdrawal is to wean the patient off using tapering doses. In patients treated for insomnia, recurrence of sleeplessness during withdrawal is probable. Hence, physicians usually suggest nonpharmacologic measures to encourage sleep during withdrawal. The study may seem slightly artificial because in the tapering alone group, the treating physician was not permitted to give such advice, although researchers would probably argue that this restriction was necessary to separate pharmacologic and nonpharmacologic treatment effects. The nonpharmacologic intervention was elaborate, involving 13.5 hours of group counseling with an experienced clinical psychologist comprising behavioral, cognitive, and educational components.
ACCESSION #
13221842

 

Related Articles

  • temazepam.  // Royal Society of Medicine: Medicines;2002, p525 

    The article presents information on the benzodiazepine agent temazepam. This drug is used as a relatively short-acting hypnotic for the short-term treatment of insomnia and as a preoperative medication. It is orally administered.

  • Non-pharmacologic treatment of insomnia in persons with dementia. Shub, Denis; Darvishi, Roham; Kunik, Mark E. // Geriatrics;Feb2009, Vol. 64 Issue 2, p22 

    The article discusses the problem of insomnia among the geriatric population and offers non-pharmacologic treatments for dementia patients. Such treatments are provided which include light therapy, exercise and sleep hygiene. The three modalities are cited as part of a comprehensive sleep...

  • Options for short-term insomnia abound. Guthrle, Ellen Whippie // Pharmacy Today;Dec2004, Vol. 10 Issue 12, p10 

    Each year, some 70 million Americans experience difficulty initialing or maintaining sleep. Patients rarely speak with their physician about insomnia, though. Nonprescription sleep aids and intended to manage an occasional sleepless night and should not be used for longer term 7 days....

  • What are the benefits and risks associated with the use of benzodiazepines to treat insomnia? Lord Jr., Richard W. // Journal of Family Practice;May2000, Vol. 49 Issue 5, p468 

    The article discusses a study conducted by researchers A. M. Holbrook, R. Crowther, A. Louer, C. Cheng and D. King in 2000 concerning the benefits and risks associated with the use of benzodiazepines for treating insomnia. Information on the clinical trials conducted by the researchers to...

  • What are the benefits and risks associated with the use of benzodiazepines to treat insomnia? Lord Jr., Richard W. // Journal of Family Practice;May2000, Vol. 49 Issue 5, p468 

    The article discusses a study conducted by researchers A. M. Holbrook, R. Crowther, A. Louer, C. Cheng and D. King in 2000 concerning the benefits and risks associated with the use of benzodiazepines for treating insomnia. Information on the clinical trials conducted by the researchers to...

  • Comparative Tolerability of Newer Agents for Insomnia. Zammit, Gary // Drug Safety;2009, Vol. 32 Issue 9, p735 

    Newer treatment options for insomnia include the non-benzodiazepine hypnotics zolpidem, zolpidem-controlled release, zaleplon, zopiclone, eszopiclone and the melatonin receptor agonist, ramelteon. These compounds are generally well tolerated and present favourable safety profiles in comparison...

  • Cognitive behavioral therapy aided discontinuation of benzodiazepine in chronic insomnia.  // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p70 

    This article presents a study, which states that in older patients with chronic insomnia who had been taking a benzodiazepine every night for 3 months, cognitive behavioral therapy plus tapering (CBTT) is more effective than tapering alone (TA) for inducing benzodiazepine discontinuation....

  • Eszopiclone. Halas, Cynthia J. // American Journal of Health-System Pharmacy;1/1/2006, Vol. 63 Issue 1, p41 

    Purpose. The pharmacology, pharmacokinetics, indications, clinical efficacy, adverse effects, drug interactions, dosing, and administration of eszopiclone are discussed. Summary. The pharmacology of eszopiclone is not well understood. Eszopiclone is the S-isomer of racemic zopiclone. The...

  • Clinical: The basics - Insomnia. Barnard, Keith // GP: General Practitioner;6/26/2009, p34 

    The article offers information on insomnia. It states that doctors must examine the nature of sleeplessness in a patient, that whether its transient or long standing. Patients with transient insomnia may get cured with medical advice from general practitioners, whereas patients with long...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics